Table B.1.
Test system | Protective agent | Results | Reference |
---|---|---|---|
Pre‐ or Co‐treatment of rats after 4 weeks of OTA treatment | Melatonin | Inhibition of liver and kidney toxicity. Reduction of indicators of oxidative stress | Meki and Hussein (2001), Ozçelik et al. (2004), Abdel‐Wahhab et al. (2005), Sutken et al. (2007) |
Rats | Red wine | Inhibition of kidney toxicity. Reduction of oxidative damage | Bertelli et al. (2005) |
Rats | 2‐mercaptoethane sulfonate (thiol) | Reduced karyomegaly but did not reduce the incidence of renal tumours | Pfohl‐Leszkowicz and Manderville (2007) |
Mice | Emblica officinalis | Prevented loss of DNA, RNA and protein from liver and kidney | Verma and Chakraborty (2008) |
Mice | Emblica officinalis | Reduced lipid peroxidation in liver and kidney | Chakraborty and Verma (2010b) |
Mice | Red wine | Reduced oxidative stress and DNA strand breaks in kidney | Cipriani et al. (2011) |
Rats | Lycopene | Reduced liver and kidney DNA strand breaks | Aydin et al. (2013) |
Rats | Myricetin | Reduced oxidative stress and kidney toxicity based on histopathology | El‐Haleem et al. (2016) |
Rats | Recombinant mitochondrial manganese containing superoxide dismutase | Prevention of hypertension and reduced glomerular filtration rate; prevention of renal and tubular degeneration | Ciarcia et al. (2016) |
Rats | Inulacrithmoides extract | Reduced toxicity, reduced liver and kidney oxidative stress; reduced bone marrow micronuclei | Abdel‐Wahhab et al. (2008) |
Rats | Mitochondrial manganese containing superoxide dismutase | Prevented nephrotoxicity and reduced the loss of sodium reabsorption in kidney proximal tubules | Damiano et al. (2018a) |
Rats | Delta‐tocotrienol | Prevention of hypertension and reduced glomerular filtration rate and lowering of kidney antioxidant enzymes | Damiano et al. (2018b) |
DNA: deoxynucleic acid; OTA: ochratoxin; RNA: ribonucleic acid.